Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells

Gastroenterology

Volumn 122, Issue 7, 2002, Pages 1898-1912

  Wagner, Martin ^a   Weber, Christoph K ^a   Bressau, Frank ^a   Greten, Florian R ^a   Stagge, Volker ^a   Ebert, Matthias ^b   Leach, Steven D ^c   Adler, Guido ^a   Schmid, Roland M ^a  

^a UNIVERSITY OF ULM   (Germany)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIREGULIN; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; ELASTASE; EPIDERMAL GROWTH FACTOR RECEPTOR; ISOPROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; RAS PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ACINAR CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROGENESIS; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MITOGENESIS; MOUSE; NONHUMAN; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTO ONCOGENE; TRANSGENIC MOUSE;

EID: 0036079914     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.33594     Document Type: Article

References (36)

1. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
2. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma
3. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer
4. Tumor-suppressive pathways in pancreatic carcinoma
5. Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha
6. Role of growth factors in pancreatic cancer
7. A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor
8. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling
9. Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology
10. Overexpression of TGF alpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast
11. Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha
12. Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice
13. A murine tumor progression model for pancreatic cancer recapitulating the genetic alterations of the human disease
14. Amphiregulin: A bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate-treated human breast adenocarcinoma cell line MCF-7
15. Structure and function of human amphiregulin: A member of the epidermal growth factor family
16. Characterization of high and low molecular weight forms of amphiregulin that differ in glycosylation and peptide core length. Evidence that the NH2-terminal region is not critical for bioactivity
17. Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form
18. Induction and expression of amphiregulin in human pancreatic cancer
19. Auto- and cross-induction within the mammalian epidermal growth factor-related peptide family
20. Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon
21. A novel method for real time quantitative RT-PCR
22. A single protocol to detect transcripts of various types and expression levels in neural tissue and cultured cells: In situ hybridization using digoxigenin-labelled cRNA probes
23. TGF-β1 influences the relative development of the exocrine and endocrine pancreas in vitro
24. Metalloprotease-mediated ligand release regulates autocrine signaling through the epidermal growth factor receptor
25. Acinar-ductal-carcinoma sequence in transforming growth factor-alpha transgenic mice
26. Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells
27. The ErbB signaling network: Receptor heterodimerization in development and cancer
28. Signal transduction by receptors with tyrosine kinase activity
29. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation
30. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling
31. Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development
32. Precancerous conditions of pancreatic carcinoma
33. Progression model for pancreatic cancer
34. p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma
35. Genetic progression in the pancreatic ducts
36. Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland